NCT00415779 ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1
NCT00216060 Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy Status TERMINATED Phase PHASE3
NCT00003533 Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE2